<DOC>
	<DOCNO>NCT02963935</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose trial investigate effect safety liraglutide 3.0 mg adjunct intensive behaviour therapy obesity non-specialist setting ( IBT-CMS : Intensive Behaviour Therapy obesity primary care set accord Centers Medicare &amp; Medicaid Services ( CMS ) visit schedule ) .</brief_summary>
	<brief_title>Effect Safety Liraglutide 3.0 mg Adjunct Intensive Behaviour Therapy Obesity Non-specialist Setting</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial BMI equal 30 kg/m^2 Male female , age 18 year old time signing informed consent HbA1c ( glycosylated haemoglobin ) equal 6.5 % ( screen visit ) , diagnosis type 1 type 2 diabetes mellitus Recent history cardiovascular disease ( myocardial infarction stroke within past 6 month ) , severe congestive heart failure ( NYHA class III , IV ) , second degree great heart block Personal family history Medullary Thyroid Carcinoma ( MTC ) , Multiple Endocrine Neoplasia type 2 ( MEN2 ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) Use past 90 day medication know induce significant weight loss ( e.g. , prescription weight loss medication ) weight gain ( e.g. , chronic use oral steroid , second generation antipsychotic ) History pancreatitis ( acute chronic ) History major depressive disorder within past 2 year Any lifetime history suicide attempt Inadequately treat blood pressure define Grade 3 hypertension high ( Systolic equal 180 mmHg diastolic equal 110 mmHg ) History malignancy ( except nonmelanoma skin cancer ) within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>